Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Synta Pharma (SNTA) Prices 22M Common Offering at $1.75/Share
March 31, 2015 9:16 AM EDTSynta Pharma (NASDAQ: SNTA) has priced an underwritten public offering of 22,000,000 shares of its common stock at a price to the public of $1.75 per share. Gross proceeds to Synta are expected to be approximately $38.5 million, before deducting the underwriting discounts and commissions and... More
Synta Pharma (SNTA) to Offer Common Shares
March 30, 2015 4:02 PM EDTSynta Pharma (NASDAQ: SNTA) announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering... More



